Bioenergetic characterization of mouse podocytes.
Mitochondrial dysfunction contributes to podocyte injury, but normal podocyte bioenergetics have not been characterized. We measured oxygen consumption rates (OCR) and extracellular acidification rates (ECAR), using a transformed mouse podocyte cell line and the Seahorse Bioscience XF24 Extracellular Flux Analyzer. Basal OCR and ECAR were 55.2 +/- 9.9 pmol/min and 3.1 +/- 1.9 milli-pH units/min, respectively. The complex V inhibitor oligomycin reduced OCR to approximately 45% of baseline rates, indicating that approximately 55% of cellular oxygen consumption was coupled to ATP synthesis. Rotenone, a complex I inhibitor, reduced OCR to approximately 25% of the baseline rates, suggesting that mitochondrial respiration accounted for approximately 75% of the total cellular respiration. Thus approximately 75% of mitochondrial respiration was coupled to ATP synthesis and approximately 25% was accounted for by proton leak. Carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), which uncouples electron transport from ATP generation, increased OCR and ECAR to approximately 360% and 840% of control levels. FCCP plus rotenone reduced ATP content by 60%, the glycolysis inhibitor 2-deoxyglucose reduced ATP by 35%, and 2-deoxyglucose in combination with FCCP or rotenone reduced ATP by >85%. The lactate dehydrogenase inhibitor oxamate and 2-deoxyglucose did not reduce ECAR, and 2-deoxyglucose had no effect on OCR, although 2-deoxyglucose reduced ATP content by 25%. Mitochondrial uncoupling induced by FCCP was associated with increased OCR with certain substrates, including lactate, glucose, pyruvate, and palmitate. Replication of these experiments in primary mouse podocytes yielded similar data. We conclude that mitochondria play the primary role in maintaining podocyte energy homeostasis, while glycolysis makes a lesser contribution.
Abe
Yoshifusa
Y
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1268, USA.
Sakairi
Toru
T
Kajiyama
Hiroshi
H
Shrivastav
Shashi
S
Beeson
Craig
C
Kopp
Jeffrey B
JB
D000818:Animals; D002460:Cell Line; D002461:Cell Line, Transformed; D006019:Glycolysis / Q000502:physiology*; D007678:Kidney Glomerulus / Q000166:cytology / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D008928:Mitochondria / Q000737:chemistry / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010101:Oxygen Consumption / Q000502:physiology; D050199:Podocytes / Q000166:cytology / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D013379:Substrate Specificity / Q000502:physiology
Kidney Int. 2006 Jun;69(11):2101-6
16625147
Biochim Biophys Acta. 2007 Feb;1767(2):170-7
17266920
J Am Soc Nephrol. 2007 Oct;18(10):2773-80
17855635
Cell Biochem Funct. 2003 Mar;21(1):1-9
12579515
Histochem Cell Biol. 2008 Nov;130(5):957-66
18751721
Diabetes Obes Metab. 2003 Sep;5(5):295-301
12940866
Free Radic Biol Med. 2009 Apr 15;46(8):1149-57
19439219
Am J Physiol Cell Physiol. 2007 Feb;292(2):C719-28
17050618
Am J Pathol. 2009 Apr;174(4):1191-202
19264907
Kidney Int. 2001 Apr;59(4):1236-43
11260383
Eur J Biochem. 2002 Jan;269(1):19-28
11784294
Am J Physiol Cell Physiol. 2007 Jan;292(1):C125-36
16971499
Am J Nephrol. 2009;29(3):153-63
18753740
Am J Pathol. 2002 Sep;161(3):799-805
12213707
J Neurochem. 2009 May;109(4):1179-91
19519782
Eur J Biochem. 1986 Jul 1;158(1):159-65
2874024
Eur J Biochem. 1974 Dec 16;50(1):305-15
4452361
Am J Hum Genet. 2006 Dec;79(6):1125-9
17186472
Am J Physiol Cell Physiol. 2008 Jul;295(1):C29-37
18463229
FASEB J. 2000 Sep;14(12):1793-800
10973929
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8412-7
12829793
Pflugers Arch. 2004 Feb;447(5):619-28
12739169
Free Radic Biol Med. 2004 Mar 15;36(6):765-73
14990355
Biochem Soc Trans. 2005 Nov;33(Pt 5):897-904
16246006
J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S85-7
14684680
AAPS J. 2008;10(1):193-9
18446519
Free Radic Biol Med. 2005 Jan 1;38(1):12-23
15589367